Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience

被引:14
作者
De-la-Cruz-Ku, Gabriel [1 ]
Luyo, Marianne [2 ]
Morante, Zaida [3 ]
Enriquez, Daniel [3 ]
Moller, Mecker G. [4 ]
Chambergo-Michilot, Diego [1 ,5 ]
Flores, Lucero [1 ]
Luque, Renato [1 ,6 ]
Saavedra, Antonella [1 ,6 ]
Eyzaguirre-Sandoval, Miguel E. [1 ,6 ]
Lujan-Peche, Maria G. [1 ,6 ]
Noel, Naysha [1 ]
Calderon, Hafid [1 ,6 ]
Razuri, Cesar [7 ]
Fuentes, Hugo A. [3 ]
Manuel Cotrina, Jose [3 ]
Neciosup, Silvia P. [3 ]
Araujo, Jhajaira [8 ]
Lema, Alexandra [9 ]
Pinto, Joseph [8 ]
Gomez, Henry L. [3 ]
Valcarcel, Bryan [10 ]
机构
[1] Univ Cient Sur UCSUR, Sch Med, Lima, Peru
[2] Univ Peruana Cayetano Heredia, Lima, Peru
[3] Inst Nacl Enfermedades Neoplas, Lima, Peru
[4] Univ Miami, Miller Sch Med, Div Surg Oncol, Jackson Mem Hosp,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[5] Tau RELAPED Grp, Trujillo, Peru
[6] Soc Cient Estudiantes Med Humana SCIEM UCSUR, Lima, Peru
[7] Hosp Nacl Mayo, Lima, Peru
[8] Oncosalud AUNA, Unidad Invest Basica & Translac, Lima, Peru
[9] Univ Cuenca, Hlth Sci Fac, Cuenca, Ecuador
[10] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA
来源
PLOS ONE | 2020年 / 15卷 / 08期
关键词
FAMILY-HISTORY; SURVIVAL; WOMEN; PROGNOSIS; SUBTYPES; IMPACT; ASSOCIATION; RECURRENCE; MASTECTOMY; OUTCOMES;
D O I
10.1371/journal.pone.0237811
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. Methods We reviewed the medical records of new cases treated at a single institution in the period 2000-2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. Results Among the 2007 patients included, the median age at diagnosis was 49 years (19-95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05-3.15) and mortality (HR: 2.51, 95% CI: 2.01-3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. Conclusion The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients
    Gaceb, Hadjer
    Cherbal, Farid
    Bakour, Rabah
    Ould-Rouis, Abdelhalim
    Mahfouf, Hassen
    PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (02) : 297 - 308
  • [42] Dysfunctional mismatch repair in patients with early triple-negative breast cancer
    Muniz-Castrillo, Maria
    Boluda, Noel Blaya
    Garcia-Torralba, Esmeralda
    Jimenez-Fonseca, Paula
    del Rey, Carmen Gonzalez
    Balbin, Milagros
    Luengo-Gil, Gines
    de la Pena, Francisco Ayala
    Gonzalez, Emilio Esteban
    Carmona-Bayonas, Alberto
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [43] Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
    Yin, Wen-Jin
    Lu, Jin-Song
    Di, Gen-Hong
    Lin, Yan-Ping
    Zhou, Li-Heng
    Liu, Guang-Yu
    Wu, Jiong
    Shen, Kun-Wei
    Han, Qi-Xia
    Shen, Zhen-Zhou
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) : 325 - 333
  • [44] Sonographic Features of Triple-Negative and Non-Triple-Negative Breast Cancer
    Wojcinski, Sebastian
    Soliman, Amr A.
    Schmidt, Julia
    Makowski, Lars
    Degenhardt, Friedrich
    Hillemanns, Peter
    JOURNAL OF ULTRASOUND IN MEDICINE, 2012, 31 (10) : 1531 - 1541
  • [45] Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer
    Yu, Ke-Da
    Zhu, Rui
    Zhan, Ming
    Rodriguez, Angel A.
    Yang, Wei
    Wong, Stephen
    Makris, Andreas
    Lehmann, Brian D.
    Chen, Xi
    Mayer, Ingrid
    Pietenpol, Jennifer A.
    Shao, Zhi-Ming
    Symmans, W. Fraser
    Chang, Jenny C.
    CLINICAL CANCER RESEARCH, 2013, 19 (10) : 2723 - 2733
  • [46] Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast Cancer
    Wang, Fei
    Zheng, Wei
    Bailey, Christina E.
    Mayer, Ingrid A.
    Pietenpol, Jennifer A.
    Shu, Xiao-Ou
    CANCER RESEARCH, 2021, 81 (04) : 1163 - 1170
  • [47] Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis
    Perez, Carmen A.
    Zumsteg, Zachary S.
    Gupta, Gaorav
    Morrow, Monica
    Arnold, Brittany
    Patil, Sujata M.
    Traina, Tiffany A.
    Robson, Mark E.
    Wen, Yong H.
    McCormick, Beryl
    Powell, Simon N.
    Ho, Alice Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 497 - 506
  • [48] Body mass index and weight change in relation to triple-negative breast cancer survival
    Bao, Ping-Ping
    Cai, Hui
    Peng, Peng
    Gu, Kai
    Su, Yinghao
    Shu, Xiao-Ou
    Zheng, Ying
    CANCER CAUSES & CONTROL, 2016, 27 (02) : 229 - 236
  • [49] The evolution in management of patients with subcentimeter, node-negative, triple-negative breast cancer
    Wolfe, Emily
    Corsetti, Ralph
    Bolton, John S.
    Stolier, Alan J.
    Fuhrman, George M.
    AMERICAN JOURNAL OF SURGERY, 2013, 206 (06) : 888 - 892
  • [50] Pathogenesis of Triple-Negative Breast Cancer
    Derakhshan, Fatemeh
    Reis-Filho, Jorge S.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 181 - 204